All dysplastic lesions of the cervix uteri, vagina or vulva

N14_FEMALE_GENITAL_DYSPLASIA_ALL

No definition available.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector
diagram bullet

Apply sex-specific rule

Sex only females

219462

diagram downward connector

Check conditions None

219462

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 N87|N89[0-3]|N90[0-3]|D06|D071|D072
Hospital discharge: ICD-9 6221A|6221B|6221C|0781C|2331A|2333A|6230B|6230C|2333B
Cause of death: ICD-10 N87|N89[0-3]|N90[0-3]|D06|D071|D072
Cause of death: ICD-9 6221A|6221B|6221C|0781C|2331A|2333A|6230B|6230C|2333B

2 out of 7 registries used, show all original rules.

9590

diagram downward connector

Check minimum number of events None

9590

diagram downward connector

Include endpoints None

9590

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

9227

diagram downward connector
N14_FEMALE_GENITAL_DYSPLASIA_ALL

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze DF7

Similar endpoints

Summary Statistics

Key figures

All Female Male
Number of individuals 9227 9227 -
Unadjusted prevalence (%) 2.45 4.38 -
Mean age at first event (years) 38.37 38.37 -

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.02 1.08 [0.72, 1.61] 7.1e-1 185
15 years 0.00 0.73 [0.48, 1.11] 1.4e-1 76
5 years 0.00 1.55 [0.98, 2.44] 5.9e-2 36
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: N14_FEMALE_GENITAL_DYSPLASIA_ALL – All dysplastic lesions of the cervix uteri, vagina or vulva
GWS hits: 3

Survival analyses between endpoints

Plot

before All dysplastic lesions of the cervix uteri, vagina or vulva
after All dysplastic lesions of the cervix uteri, vagina or vulva

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after All dysplastic lesions of the cervix uteri, vagina or vulva

Endpoint not on priority list, no data to show.